N-(2-((R)-3-(1-(1-((R)-1-(2,4-Dichlorophenyl)ethyl)-3-methyl-1H-pyrazolo[3,4-b]pyrazin-6-yl)azetidin-3-yl)piperidin-1-yl)ethyl)methanesulfonamide

ID: ALA4647188

PubChem CID: 134210845

Max Phase: Preclinical

Molecular Formula: C25H33Cl2N7O2S

Molecular Weight: 566.56

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nn([C@H](C)c2ccc(Cl)cc2Cl)c2nc(N3CC([C@H]4CCCN(CCNS(C)(=O)=O)C4)C3)cnc12

Standard InChI:  InChI=1S/C25H33Cl2N7O2S/c1-16-24-25(34(31-16)17(2)21-7-6-20(26)11-22(21)27)30-23(12-28-24)33-14-19(15-33)18-5-4-9-32(13-18)10-8-29-37(3,35)36/h6-7,11-12,17-19,29H,4-5,8-10,13-15H2,1-3H3/t17-,18+/m1/s1

Standard InChI Key:  UBQUARZVFOTNKI-MSOLQXFVSA-N

Molfile:  

 
     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   13.8881  -14.4494    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.4837  -15.1593    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   14.3007  -15.1546    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.7197  -15.4069    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.7185  -16.2264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4266  -16.6354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1363  -16.2260    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.4248  -14.9980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1306  -15.4063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7371  -14.8613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4060  -14.1160    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.5951  -14.2006    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.0488  -13.5929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3019  -12.8159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2493  -13.7621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1019  -12.6482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3552  -11.8721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8086  -11.2634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0056  -11.4361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7560  -12.2120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9571  -12.3839    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   20.0608  -10.4861    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   21.5362  -15.0319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0105  -16.6345    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2230  -16.4236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0109  -17.2128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8001  -17.4249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3023  -17.6253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5951  -17.2140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8892  -17.6185    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8843  -18.4361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5916  -18.8474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3037  -18.4412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1834  -17.2067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1871  -16.3895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4813  -15.9777    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.7792  -14.7487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  9  1  0
  8  4  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  8  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  6
 14 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 14  1  0
 20 21  1  0
 18 22  1  0
 10 23  1  0
  5 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 24  1  0
 28 29  1  0
 28 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 28 26  1  1
 30 34  1  0
 34 35  1  0
 35 36  1  0
 36  2  1  0
  2 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4647188

    ---

Associated Targets(Human)

CCR4 Tclin C-C chemokine receptor type 4 (2819 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 566.56Molecular Weight (Monoisotopic): 565.1793AlogP: 3.75#Rotatable Bonds: 8
Polar Surface Area: 96.25Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.35CX Basic pKa: 8.24CX LogP: 2.86CX LogD: 1.96
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.44Np Likeness Score: -1.47

References

1. Robles O, Jackson JJ, Marshall L, Talay O, Chian D, Cutler G, Diokno R, Hu DX, Jacobson S, Karbarz E, Kassner PD, Ketcham JM, McKinnell J, Meleza C, Reilly MK, Riegler E, Shunatona HP, Wadsworth A, Younai A, Brockstedt DG, Wustrow DJ, Zibinsky M..  (2020)  Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as a Single Agent and in Combination with Checkpoint Inhibitors.,  63  (15): [PMID:32667798] [10.1021/acs.jmedchem.0c00988]

Source